These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 27385599)
1. Leukoreduced red blood cell transfusions do not induce platelet glycoprotein antibodies in patients with sickle cell disease. Nickel RS; Winkler AM; Horan JT; Hendrickson JE Transfusion; 2016 Sep; 56(9):2267-73. PubMed ID: 27385599 [TBL] [Abstract][Full Text] [Related]
2. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease. Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976 [TBL] [Abstract][Full Text] [Related]
3. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. McPherson ME; Anderson AR; Castillejo MI; Hillyer CD; Bray RA; Gebel HM; Josephson CD Pediatr Blood Cancer; 2010 Apr; 54(4):552-8. PubMed ID: 19890898 [TBL] [Abstract][Full Text] [Related]
5. Alloimmunization in sickle cell anemia in the era of extended red cell typing. O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932 [TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Natukunda B; Schonewille H; Ndugwa C; Brand A Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion. Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee ME; Kean LS; Hendrickson JE Am J Hematol; 2015 Dec; 90(12):1135-41. PubMed ID: 26361243 [TBL] [Abstract][Full Text] [Related]
8. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study. Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378 [TBL] [Abstract][Full Text] [Related]
9. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease. Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408 [TBL] [Abstract][Full Text] [Related]
10. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD). Leal I; Dos Santos TD; Gilli S; Castilho L Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224 [TBL] [Abstract][Full Text] [Related]
11. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients. Lo SC; Chang JS; Lin SW; Lin DT Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666 [TBL] [Abstract][Full Text] [Related]
12. Frequency and characterization of platelet-specific antibodies in patients who received multiple platelet transfusions. Lo SC; Lin DT; Lin SW; Chang JS J Formos Med Assoc; 2000 Dec; 99(12):902-5. PubMed ID: 11155742 [TBL] [Abstract][Full Text] [Related]
14. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis. Godfrey GJ; Lockwood W; Kong M; Bertolone S; Raj A Pediatr Blood Cancer; 2010 Dec; 55(6):1134-7. PubMed ID: 20979172 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies. Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842 [TBL] [Abstract][Full Text] [Related]
16. HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis). Wong K; Lai WK; Jackson DE Vox Sang; 2022 Nov; 117(11):1251-1261. PubMed ID: 36102140 [TBL] [Abstract][Full Text] [Related]
17. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease. Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719 [TBL] [Abstract][Full Text] [Related]
18. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods. Campbell-Lee SA; Gvozdjan K; Choi KM; Chen YF; Saraf SL; Hsu LL; Gordeuk VR; Strauss RG; Triulzi DJ Transfusion; 2018 Jul; 58(7):1588-1596. PubMed ID: 29570817 [TBL] [Abstract][Full Text] [Related]
19. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Harm SK; Yazer MH; Monis GF; Triulzi DJ; Aubuchon JP; Delaney M Am J Clin Pathol; 2014 Feb; 141(2):256-61. PubMed ID: 24436274 [TBL] [Abstract][Full Text] [Related]
20. Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease. Desai PC; Deal AM; Pfaff ER; Qaqish B; Hebden LM; Park YA; Ataga KI Am J Hematol; 2015 Aug; 90(8):691-5. PubMed ID: 25963831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]